A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can rapidly and safely reduce symptoms of severe depression. The findings indicate that a single dose of a fast-acting psychedelic compound, administered intravenously, provides sustained relief for up to three months. This research offers early evidence for a mental health treatment that requires much less time in a clinic than other psychedelic therapies. Dimethyltryptamine, commonly known as DMT, is a naturally occurring compound that produces intense but short-lived psychedelic effects. It works by interacting with the serotonin system in the brain, which plays a major role in regulating mood and processing emotions. While other psychedelics like psilocybin have shown promise for treating mood disorders, their effects tend to last four to six hours. This extended duration requires a full day of medical supervision, making the treatment expensive and difficult to scale for widespread use. When given directly into a vein, the psychedelic effects of DMT last only twenty to thirty minutes. The scientists behind the new study wanted …